Skip to search formSkip to main contentSkip to account menu

CORT 108297

Known as: CORT108297 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Aza CompoundsHeterocyclic Compounds, 4 or More Rings

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract PD3-02: Second-generation selective glucocorticoid receptor modulators in triple-negative breast cancer
Triple-negative breast cancer (TNBC) lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and HER2. A… 
2016
2016
Abstract 334: Novel selective glucocorticoid receptor modulators (SGRMs) in castration-resistant prostate cancer
(A) Introduction: Because of the central role of androgen receptor (AR) signaling in prostate cancer (PC), AR inhibition is the… 
2012
2012
Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia
Mifepristone, a glucocorticoid and progesterone receptor antagonist, has been shown to attenuate retrograde amnesia induced by… 
2011
2011
Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
Previous research has shown that mifepristone can prevent and reverse weight gain in animals and human subjects taking… 
2010
2010
Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine‐induced weight gain
Use of antipsychotic medications has been associated consistently with weight gain and metabolic disturbances, and a subsequent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)